Chaobin He

sun yatsen university

H指数:23

被引数:1,316

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation

增强胰腺癌治疗：H101溶瘤病毒在不可逆电穿孔中的作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-03-181

The Prognostic Significance of the CALLY Index in Ampullary Carcinoma: An Inflammation-Nutrition Retrospective Analysis

inflammation research

IF4.1

2025-01-011

Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer (vol 502, pg 9, 2021)

CANCER LETTERS

IF10.1

2024-05-010

OAAI

Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma

肝内胆管癌基于阳性淋巴结列线图的改良分期系统

CANCER CELL INTERNATIONAL

IF6

2023-07-292

OAAI

An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-06-087

OAAI

Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-082

OAAI

Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer

inflammation research

IF4.1

2021-09-0118

Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-173

OAAI

An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection

inflammation research

IF4.1

2021-05-016

Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer

CANCER LETTERS

IF10.1

2021-04-0132

PREAI

Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-0132

OAAI

Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation

inflammation research

IF4.1

2021-04-011

The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer

不可逆电穿孔通过调控HMGB1-RAGE-MAPK轴促进M1型巨噬细胞极化在胰腺癌中的作用

ONCOIMMUNOLOGY

IF6.3

2021-03-1147

OAAI

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers

inflammation research

IF4.1

2021-03-0116

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer

局部晚期胰腺癌新辅助化疗后不可逆电穿孔与转化切除术的生存比较

FRONTIERS IN ONCOLOGY

IF3.3

2021-02-027

OAAI

The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy

BMC CANCER

IF3.4

2020-10-1012

OAAI

SYPL1 Inhibits Apoptosis in Pancreatic Ductal AdenocarcinomaviaSuppression of ROS-Induced ERK Activation

FRONTIERS IN ONCOLOGY

IF3.3

2020-09-1517

OAAI

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection

预测根治性切除术后胰腺导管腺癌复发患者生存的新列线图

FRONTIERS IN ONCOLOGY

IF3.3

2020-09-036

OAAI

Score for the Survival Probability of Patients With Orbital Rhabdomyosarcoma After Surgery: A Long-Term and Large Cohort Study

FRONTIERS IN ONCOLOGY

IF3.3

2020-08-272

OAAI

A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment

一种基于大队列的新型预测工具，用于确定不可逆电穿孔治疗后局部晚期胰腺癌患者的癌症特异性生存概率

FRONTIERS IN ONCOLOGY

IF3.3

2020-06-303

OAAI

Chaobin He

个人简介

教育背景

工作经历

荣誉奖项

研究方向